Excretion of citalopram in breast milk

British Journal of Clinical Pharmacology

Volumn 44, Issue 3, 1997, Pages 295-298

  Spigset, Olav ^a   Carleborg, Lena ^a   Öhman, Robert ^b   Norström, Åke ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ÖSTERSUND HOSPITAL   (Sweden)

Author keywords

Breast milk; Citalopram; Lactation; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BREAST MILK; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG MILK LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LACTATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEADY STATE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030979693     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.t01-1-00576.x     Document Type: Article

References (20)

1. Robinson GE, Stewart DE. Postpartum psychiatric disorders. Can Med Assoc J 1986; 134: 31-37.
2. Pons G, Rey E, Matheson I. Excretion of psychoactive drugs into breast milk. Clin Pharmacokinet 1994; 27: 270-289.
3. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153: 1132-1137.
4. Yosida K, Kumar R. Breast feeding and psychotropic drugs. Int Rev Psychiatry 1996; 8: 117-124.
5. Nightingale SL. Fluoxetine labeling revised to identify phenytoin interaction and to recommend against use in nursing mothers. JAMA 1994; 271: 1067.
6. Sindrup SH, Brøsen K, Hansen MGJ, Aaes-Jorgensen T, Overø KF, Gram LF. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms. Ther Drug Monit 1993; 15: 11-17.
7. Spigset O, Carleborg L, Hedenmalm K, Dahlqvist R. Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans. Clin Pharmacol Ther 1995; 58: 399-403.
8. Wilson JT, Brown RD, Hinson JL, Dailey JW. Pharmacokinetic pitfalls in the estimation of the breast milk/ plasma ratio for drugs. Ann Rev Pharmacol Toxicol 1985; 25: 667-689.
9. Matheson I, Skjaeraasen J. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients. Eur Clin Pharmacol 1988; 35: 217-220.
10. Kemp J, Ilett FK, Booth J, Hackett LP. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985; 20: 497-499.
11. Ilett KF, Lebedevs TH, Wojnur-Horton RE et al. The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol 1993; 33: 635-639.
12. Dollery C (ed). Therapeutie drugs. Edinburgh: Churchill Livingstone, 1991: N129-N133.
13. Dollery C (ed). Therapeutic drugs. Supplement 2. Edinburgh: Churchill Livingstone, 1994: 47-53.
14. Isenberg KE. Excretion of fluoxetine in human breast milk. J Clin Psychiatry 1990; 51: 169.
15. Burch KJ, Wells BG. Fluoxetine/norfluoxetine concentrations in human breast milk. Pediatrics 1992; 89: 676-677.
16. Lester BM, Cucca J, Andreozzi L, Flanagan F, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993; 32: 1253-1255.
17. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996; 36: 42-47.
18. Wright S, Dawling S, Ashford JJ. Excretion of fluvoxamine in breast milk. Br J Clin Pharmacol 1991; 31: 209.
19. Altshuler LL, Burt VK, McMullen M, Hendrick V. Breastfeeding and sertraline: a 24-hour analysis. J Clin Psychiatry 1995; 56: 243-245.
20. Spigset O, Carleborg L, Norström Å, Sandlund M. Paroxetine level in breast milk. J Clin Psychiatry 1996; 57: 39.